Elda Tagliabue
Istituto Nazionale dei Tumori
222 papers found
Refreshing results…
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
Download from doi.orgTaxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
Download from doi.org“Omics†and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas
Download from doi.orgActivated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.